Less than 50% of employers cover GLP-1 drugs for weight loss: JPM survey
"Coverage for these weight-loss drugs has significant cost implications for employers, as a previous KFF analysis estimated ...
Newport Beach Independent22h
Bariatric Surgeons Face Decline As GLP-1s Gain Ground In Obesity Treatment
Recent market research reveals that glucagon-like peptide-1 (GLP-1) injections are set to dominate the obesity treatment ...